Abstract: A new synthesis of (Aib-Pro)n oligopeptides (n = 2, 3, and 4) via azirine coupling by using the dipeptide synthon methyl N-(2,2-dimethyl-2H-azirin-3-yl)-l-prolinate (1b; Fig. 1 ) is presented. The most important feature of the employed protocol is that no activation of the acid component is necessary, i.e., no additional reagents are required, and the coupling reaction is performed under mild conditions at room temperature. As an attempt to provide an answer to the question of the preferred conformation of the prepared molecules, we carried out experiments by using NMR techniques and X-ray crystallography. For example, in the case of the hexapeptide 11, it was possible to compare the conformations in the crystalline state and in solution. After the selective hydrolysis of the methyl ester p-BrBz-(Aib-Pro)4-OMe (13) under basic conditions, the corresponding octapeptide acid was obtained, which was then converted into the octapeptide amide p-BrBz-(Aib-Pro)4-NHC6H13 (15) by using standard coupling conditions and activating reagents (HOBt/TBTU/DIEA) of the peptide synthesis. The conformation of this compound, as well as those of the tetrapeptides 14 and 18, was also established by X-ray crystallography and in solution by NMR techniques. In the crystalline state, a beta-bend ribbon structure is the preferred conformation, and similar conformations are formed in solution. A new synthesis of (Aib-Pro) n oligopeptides (n ¼ 2, 3, and 4) via azirine coupling by using the dipeptide synthon methyl N-(2,2-dimethyl-2H-azirin-3-yl)-l-prolinate (1b; Fig. 1 ) is presented. The most important feature of the employed protocol is that no activation of the acid component is necessary, i.e., no additional reagents are required, and the coupling reaction is performed under mild conditions at room temperature. As an attempt to provide an answer to the question of the preferred conformation of the prepared molecules, we carried out experiments by using NMR techniques and X-ray crystallography. For example, in the case of the hexapeptide 11, it was possible to compare the conformations in the crystalline state and in solution. After the selective hydrolysis of the methyl ester p-BrBz-(Aib-Pro) 4 -OMe (13) under basic conditions, the corresponding octapeptide acid was obtained, which was then converted into the octapeptide amide p-BrBz-(Aib-Pro) 4 -NHC 6 H 13 (15) by using standard coupling conditions and activating reagents (HOBt/TBTU/DIEA) of the peptide synthesis. The conformation of this compound, as well as those of the tetrapeptides 14 and 18, was also established by X-ray crystallography and in solution by NMR techniques. In the crystalline state, a b-bend ribbon structure is the preferred conformation, and similar conformations are formed in solution.
1. Introduction. -Peptaibol antibiotics, including the well-known alamethicin [2] , form an important class of linear peptides of fungal origin, which are characterized by a high content of a,a-disubstituted glycines, e.g., a-aminoisobutyric acid (Aib) and isovaline (Iva), an N-terminal Ac group, and a C-terminal b-amino alcohol [3] . Due to the conformational constraints imposed on the peptide backbone by the presence of a,a-dialkylated glycyl residues, Aib-containing peptides generally form helical structures, either a, 3 10 , or mixed a/3 10 helices, depending on the length of the peptide and the number and location of Aib residues [4] . Helix-like structures have also been described in the case of (Aib-Pro) n oligopeptides and (Xaa-Yaa-Aib-Pro) segments, which give rise to the b-bend ribbon spiral [4a] [5], a sub-class of 3 10 -helices. It has been suggested that the alternation of a conformationally restricted N-alkylated amino acid residue such as Pro, which disrupts the conformation-stabilizing H-bonding schemes observed in helices, and a helix-forming residue such as Aib, may give rise to the formation of a b-bend ribbon [4a] . Helical structures are involved in the antimicrobial properties of peptaibols, due to their ability to interact with biological membranes, to modify their permeability and to form voltage-dependent trans-membrane ion channels [6] .
Since the discovery of 2,2-disubstituted 2H-azirin-3-amines of type 1a (Fig. 1) as synthons for a,a-disubstituted glycines [7] , we have reported their use in the synthesis of several peptaibols and peptaibol segments [8] , as well as sterically congested model peptides [9] , via the so-called azirine/oxazolone method. Furthermore, it has been demonstrated that the building blocks 1 may be used in a modified solid-phase peptide synthesis [8h] [10] . The key steps of this method are the spontaneous reaction of an amino or peptide acid 2 with 1a leading to peptide amides 3 with the backbone extended by an a-methylalanine (Aib), followed by the acid-catalyzed formation of an intermediate oxazolone 4 and coupling of the next amino component to give 5 (Scheme 1). Alternatively, under hydrolytic conditions, selective hydrolysis of the intermediates 4 leads to the acids 6, which can be used for the next azirine coupling.
Furthermore, methyl N-(2,2-dimethyl-2H-azirin-3-yl)-l-prolinates 1b and 1c have been prepared and found to be suitable as dipeptide synthons for the sequence Aib-Pro and Aib-Hyp (Hyp ¼ 4-hydroxyproline) [8b] [11] . These building blocks have been employed in the synthesis of the peptaibol antibiotic trichovirin I 1B and segments of trichovirin I 4A [8b] [8e], a segment of zervamicin II-2 [8d], and hypomurocin A1 [8f] .
In the present study, we have used the Aib-Pro synthon 1b for the synthesis of some terminally protected sequential peptides of the type p-BrBz-(Aib-Pro) n -OMe, p-BrBz-(Aib-Pro) n -NHC 6 H 13 , and p-MeOBz-(Aib-Pro) n -OMe. We also present the results of the conformational studies on these peptides in the solid state and in solution, and the evidence for the b-bend ribbon structure, which has already been reported for analogous peptides with other terminal groups [4a] [5]. 2. Results and Discussion. -2.1. Synthesis of the Terminally Protected p-BrBz-(AibPro) n -OMe and p-BrBz-(Aib-Pro) n -NHC 6 H 13 . The dipeptide methyl ester 7 was synthesized in good yield by treatment of 4-bromobenzoic acid (p-BrBzOH) with azirine 1b (azirine coupling). A solution of p-BrBzOH (1 mol-equiv.) in THF was cooled to 08, 1b (1.1 mol-equiv.) was added, and the mixture was stirred for 103 h at room temperature. The product was purified by column chromatography to give 7 in 89% yield (Scheme 2). Base-catalyzed hydrolysis of 7 with LiOH · H 2 O (4 mol-equiv.) in THF/MeOH/H 2 O gave the corresponding dipeptide acid 8 in excellent yield (96%). The isolated product was pure enough to be used in the next coupling with another AibPro unit 1b. To a solution of 8 (1 mol-equiv.) in CH 2 Cl 2 at 08 was added 1b (1.1 molequiv.), and the mixture was stirred for 27 h at room temperature. After chromatographic purification, the tetrapeptide p-BrBz-(Aib-Pro) 2 -OMe (9) was obtained quantitatively (99%). Subsequent hydrolysis with LiOH · H 2 O (4 mol-equiv.) in THF/MeOH/H 2 O afforded the corresponding acid 10 in 93% yield. By repeating the sequence of azirine coupling and hydrolysis, the hexapeptides 11 (ester) and 12 (acid) were prepared in high-to-excellent yields, whereas the azirine coupling of 12 with 1b furnished the octapeptide ester 13 in only 24% yield.
In the case of the hexapeptide ester 11, suitable crystals for the X-ray crystalstructure determination were obtained by slow evaporation of the solvent from a solution of 11 in CH 2 Cl 2 /AcOEt. The molecular structure is shown in Fig. 2 . The absolute configuration (S,S,S) was confirmed independently by the diffraction experiment and agrees with that expected from the synthesis of the compound. The compound contains highly disordered or diffuse solvent molecules. The molecule 11 forms a helix which is held in place in the usual way by two intramolecular H-bonds. N(7)ÀH and N(13)ÀH interact with the amide O-atoms that are seven atoms back along the peptide backbone. Each of these interactions has the graph set [12] motif of S (10) . N(1)ÀH, which is unable to form an intramolecular interaction because of its position in the backbone, forms an intermolecular H-bond with the amide O(12')-atom near the middle of a different neighboring molecule. This interaction links the molecules into extended chains which run parallel to the [010] direction and have a graph set motif of C(14) (Fig. 3) . As all possible H-bonds involving the NÀH groups have been detected, there are no potential donor interactions with any of the solvent molecules.
Starting with the tetrapeptide acid 10, the corresponding hexylamide 14 was prepared by a standard peptide-coupling method with 2-[(1H-benzotriazol-1-yl)oxy]-1,1,3,3-tetramethyluronium tetrafluoroborate (TBTU) in the presence of 1-hydroxybenzotriazole (HOBt) and (ethyl)(diisopropyl)amine (DIEA, EtN(i-Pr) 2 ) in CH 2 Cl 2 at room temperature (Scheme 3). After usual workup, chromatographic purification gave 14 in 90% yield.
Suitable crystals of 14 for the X-ray crystal-structure determination were grown from a solution in CH 2 Cl 2 by slow evaporation of the solvent. The molecular structure is depicted in Fig. 4 . The crystals are enantiomerically pure, and the absolute configuration (S,S) has been confidently determined independently by the diffraction experiment. The asymmetric unit contains one peptide and two CH 2 Cl 2 molecules, one of which is highly disordered. Each NÀH group of the peptide molecule acts as a donor for H-bonds. Two of the interactions are intramolecular H-bonds which form a regular pattern along the peptide chain and lend the molecule a helical conformation: N(1)ÀH and N(6)ÀH interact with the amide O-atoms that are seven atoms further along the peptide backbone. Each of these interactions has the graph set motif of S (10) . N(12)ÀH forms an intermolecular H-bond with the first amide O(1')-atom at the opposite end of a neighboring molecule. These interactions link the molecules into extended chains which run parallel to the [001] direction and have a graph set motif of C(14) (Fig. 5) .
In analogy to the sequence 9 ! 10 ! 14, the octapeptide ester 13 was transformed into the corresponding hexyl amide 15 (Scheme 3). Saponification of 13 with LiOH · H 2 O (4 mol-equiv.) in THF/MeOH/H 2 O furnished the octapeptide acid in 89% yield, which was reacted with hexylamine by using TBTU/HOBt/DIEA. After chromatographic purification of the crude reaction mixture, the desired octapeptide amide pBrBz-(Aib-Pro) 4 -NHC 6 H 13 (15) was obtained in 44% yield.
Crystals of 15 suitable for the X-ray crystal-structure determination were obtained from the mixture CH 2 Cl 2 /AcOEt/hexane by slow evaporation of the solvent. The molecular structure is shown in Fig. 6 . The crystals are enantiomerically pure, and the absolute configuration of the molecule has been confidently determined independently by the diffraction experiment. This confirmed that the compound has the expected (S)-configuration at each stereogenic center. The helical conformation of the molecule is controlled by four intramolecular H-bonds. N(1)ÀH, N(7)ÀH, N(13)ÀH, and N(19)ÀH interact with the amide O-atoms that are seven atoms further along the peptide backbone. Each of these interactions has the graph set motif of S (10) . N(25)ÀH, which is unable to form an intramolecular interaction because of its position in the backbone, forms an intermolecular H-bond with the second amide O(5')-atom from the opposite end of a neighboring molecule. This interaction links the molecules into extended chains which run parallel to the [110] direction and have a graph set motif of C(23) (Fig. 7) 2 ).
2.2. Synthesis of the Terminally Protected p-MeOBz-(Aib-Pro) n -OMe (20) . With the aim of studying the potential influence of a MeO group in the para-position of the aromatic ring on the peptide structure, we prepared the hexapeptide p-MeOBz-(AibPro) 3 -OMe (20) Suitable crystals for the X-ray crystal-structure determination were obtained by slow evaporation of the solvent from a solution of 18 in CHCl 3 . The molecular structure is depicted in Fig. 8 . The asymmetric unit contains one peptide and one highly disordered CH 2 Cl 2 molecule plus a site which was assigned to a H 2 O molecule with only one quarter site occupancy, although this site lies quite close to the CH 2 Cl 2 molecule and may actually be a further disordered position belonging to the CH 2 Cl 2 molecule (see Exper. Part). The central five-membered ring of the peptide molecule has a disordered envelope conformation in which the envelope flap atom, C(26), flips to either side of the ring. The crystals are enantiomerically pure, however, the absolute configuration of the molecule has not been determined. The enantiomer used in the Fig. 6 . ORTEP Plot [13] of the molecular structure of 15 (arbitrary numbering of the atoms; 50% probability ellipsoids; H-atoms bonded to C-atoms omitted for clarity) refinement was based on the known (S)-configuration at C(5) and C (11) . Each NÀH group of the molecule acts as a donor for H-bonds. N(7)ÀH forms an intramolecular Hbond with the amide O-atom that is seven atoms back along the peptide backbone, thus producing a graph set motif of S (10) . N(1)ÀH forms an intermolecular H-bond with the second last amide O(9')-atom from the opposite end of a neighboring molecule. This interaction links the molecules into extended chains which run parallel to the [001] direction and have a graph set motif of C(11) (Fig. 9 ).
Scheme 4
Fig. 8. ORTEP Plot [13] of the molecular structure of one of the two conformers of 18 (arbitrary numbering of the atoms; 50% probability ellipsoids; H-atoms bonded to C-atoms and solvent molecules omitted for clarity)
Basic hydrolysis of 18 under the usual conditions led to the corresponding acid 19 in 98% yield, and the latter was coupled with 1b to give the hexapeptide p-MeOBz-(AibPro) 3 -OMe (20) in 88% yield (Scheme 4). Unfortunately, it was not possible to grow suitable crystals for the X-ray crystal-structure determination.
2.3. Conformational Studies. 2.3.1. Octapeptide Amide p-BrBz-(Aib-Pro) 4 -NHC 6 H 13 (15) . The crystal structure and packing of 15 are shown in Figs. 6 and 7, respectively. As expected, this molecule shows a helical structure of the b-bend type (see torsion angles of the peptide backbone in Table 1 ). This sub-type of the well-known 3 10 -helical structure is stabilized by four 1 4 intramolecular H-bonds between the NH groups of the Aib(3), Aib(5), and Aib (7) residues, and the NH of the hexylamide moiety and the C¼O groups of the p-BrBz moiety, and the Pro(2), Pro(4), and Pro(6) C¼O groups, respectively ( Table 2 ).
The Pro side-chain torsion angles of p-BrBz-(Aib-Pro) 4 -NHC 6 H 13 (15) are compiled in Table 3 . They show that both C(g)-endo and C(g)-exo pyrrolidine ring puckerings are observed [14] . This finding is in agreement with the results obtained by Toniolo et al. who reported that these two pyrrolidine ring conformations have also been observed in the heptapeptide p-BrBz-Aib-(Pro-Aib) 3 -OMe and in the nona- (1) Pro (2) Aib (3) Pro (4) Aib (5) Pro (6) Aib (7) Pro ( (4) 160 a ) Primed atoms refer to the molecule in the symmetry-related position 1 þ x, 1 þ y, z. 
. These findings rule out the suggestion that this parameter would have a marked effect on the backbone conformation, although some theoretical calculations have shown that the C(g)-endo state is the lowest-energy conformation for the pyrrolidine ring in poly(Aib-Pro) n peptides, which adopt fairly rigid helical structures stabilized by 1 4 intramolecular H-bonds [15] .
Information about the three-dimensional structure of the octapeptide p-BrBz-(AibPro) 4 -NHC 6 H 13 (15) in solution is available from NMR data. A simple indication for the presence of different types of H-bonds is the dependence of the NH shifts on the temperature and on the polarity of the solvent: NH groups involved in intramolecular H-bonds should show a very small dependence, whereas the chemical shifts of solventexposed NH H-atoms should be influenced more significantly [16] [17] . For the peptide 15, the involvement of the NH groups in intramolecular H-bonds was evaluated on the basis of the solvent dependence of d(NH) in CDCl 3 /(D 6 )DMSO (solvent-titration experiment [18] ) and the temperature dependence. The results obtained from the solvent-titration experiment are presented in Fig. 10 , a. Four NH groups are almost unaffected by an increase of the proportion of (D 6 )DMSO over the range from 0 to 12%. We assume that these are the NH signals of Aib(3), Aib(5), Aib(7), and the hexylamine moiety, which form four 1 4 intramolecular H-bonds as in the crystalline state. The Dd value of the NH H-atom of the Aib(1) residue is 0.353 ppm, indicating a stronger solvent dependence. The temperature dependence of the NH resonances [19] is displayed in Fig. 10 , b. The experimentally obtained Dd/DT values in the temperature range of 265 -314 K are collected in Table 4 . Whereas, the temperature coefficients of NH of Aib(3), Aib(5), Aib(7), and NHC 6 H 13 are small (À 1.66 to À 2.33 Â 10 À3 ppm/ K), the coefficient of the NH H-atom of Aib (1) is À 7.46 Â 10 À3 ppm/K, which could be interpreted as the result of the solvent exposure of this NH H-atom. From these results, it can be concluded that 15 adopts in solution a helical structure analogous to that in the crystal.
2.3.2. Octapeptide Ester p-BrBz-(Aib-Pro) 4 -OMe (13). As crystals of 13 suitable for X-ray crystallography could not be obtained, 1 H-NMR solvent-titration experiments were carried out, and the temperature dependence of the NH absorptions was determined in order to obtain information about the three-dimensional structure of the molecule in solution. As shown in Fig. 11 , a, three amide NH groups are almost unaffected by an increase of the concentration of (D 6 )DMSO in the range of 0 to 12% (v/v). Based on the similarity with the results obtained for other described molecules, we assume that these are the NH H-atoms of Aib(3), Aib(5), and Aib (7), which are able to form three 1 4 intramolecular H-bonds. On the other hand, NH of Aib (1) shows a small but significant dependence on the (D 6 )DMSO concentration. The experimental values of the temperature dependent NH resonances are shown in Fig. 11 , b, and the values Dd/DT in the range of 265 -314 K are compiled in Table 4 . Only NH of Aib (1) shows a significant dependence on the temperature. The coefficient has been determined to be À 10.2 Â 10 À3 ppm/K, which established that this NH Hatom is exposed to the solvent.
2.3.3.
Hexapeptide Ester p-BrBz-(Aib-Pro) 3 -OMe (11). The crystal structure and packing of 11 are shown in Figs. 2 and 3, respectively. In Table 5 , the most relevant torsion angles of the peptide backbone are collected. The molecule also adopts a bbend ribbon structure, which is stabilized by two 1 4 intramolecular H-bonds between the NH groups of the Aib(3) and Aib(5) residues, and the C¼O groups of the p-BrBz-moiety and Pro(2), respectively ( Table 6 ). In analogy to 15, both C(g)-endo (Pro(4)) and C(g)-exo pyrrolidine ring puckerings (Pro(2) and Pro(6)) are observed.
The involvement of the NH groups of 11 in intramolecular H-bonds in solution was evaluated on the basis of the temperature dependence of the NH chemical shifts in the temperature range of 265 -314 K (Fig. 12) . The temperature coefficients of the amide NH resonances are collected in Table 4 . The value for the NH group of Aib (1) is À 10.55 Â 10 À3 ppm/K, which indicates that this H-atom is more or less freely exposed to the solvent. On the other hand, NH(Aib(3)) and NH(Aib(5)) show temperature dependences, which are ca. 10 times smaller. Therefore, it can be concluded that they form intramolecular H-bonds.
2.3.4.
Tetrapeptide Amide p-BrBz-(Aib-Pro) 2 -NHC 6 H 13 (14) . The crystal structure and packing of 14 are depicted in Figs. 4 and 5. As expected, the molecule adopts a bbend ribbon structure, similar to the hexapeptide ester 11 (for relevant torsion angles, see Table 7 ). There is evidence for two 1 4 intramolecular H-bonds between the NH groups of the hexylamine residue and of Aib(3) and the C¼O groups of the p-BrBz moiety and Pro(2), respectively (Table 8) . Again, both types of pyrrolidine conformations are present (Pro(2): C(g)-exo; Pro(4): C(g)-endo).
Analogous 1 H-NMR experiments as in the previous cases were conducted in order to establish the H-bonding interactions and, on this basis, to propose the preferred conformation of 14 in solution. The results obtained from the solvent-titration experiment are presented in Fig. 13 , a. It is obvious that two NH resonances are almost unaffected by the polarity of the solvent; we suggest that these correspond to the NH groups of Aib(3) and the hexylamine moiety, which form two intramolecular H-bonds, as in the crystalline state. In contrast, the NH H-atom resonance of Aib (1) shows a significant solvent dependence. The experimentally obtained Dd/DT values in the temperature range of 265 -314 K are collected in Table 4 ( Fig. 13, b) . The temperature coefficient for NH of Aib (1) is À 10.58 Â 10 À3 ppm/K, which indicates that this NH Hatom is exposed to the solvent. The corresponding values for NH(Aib(3)) and NHC 6 H 13 are À 2.8 Â 10
À3 and À 2.73 Â 10 À3 ppm/K, respectively, providing a strong evidence that these NH groups are involved in intramolecular H-bonds.
2.3.5.
Tetrapeptide Ester p-MeOBz-(Aib-Pro) 2 -OMe (18). The crystal structure and packing of 18 are shown in Figs. 8 and 9 , respectively. The molecule adopts a helical conformation (b-turn; Table 9 ) with one 1 4 intramolecular H-bond between the NH group of the Aib(3) residue and the C¼O group of the p-MeOBz-moiety (Table 10 ). (2) 170 (2) a ) Primed atoms refer to the molecule in the symmetry-related position 1 1 2 À x, 1 À y, À 1 2 þ z. The central five-membered ring of the peptide molecule has a disordered envelope conformation, in which the envelope flap atom, C(26), flips to either side of the ring, and, therefore, both C(g)-endo and C(g)-exo types of puckerings are found ( Table 11) .
As in all other cases, the preferred conformation of the tetrapeptide 18 in solution was established by 1 H-NMR experiments. The results obtained from the solventtitration experiment are presented in Fig. 14, a . One NH resonance is almost unaffected when the concentration of (D 6 )DMSO was increased from 0 to 12%, and it is very likely that this is the NH signal of Aib(3), which forms a 1 4 intramolecular H-bond as in the crystalline state. The chemical shift of the other NH group was strongly dependent on the (D 6 )DMSO concentration. The experimentally obtained coefficients Dd/DT in the temperature range of 265 -314 K (Fig. 14, b) are collected in Table 4 . The temperature coefficient of the NH H-atom of Aib (1) is À 12.1 Â 10 À3 ppm/K, i.e., this NH H-atom is exposed to the solvent. The second NH group, with a temperature coefficient of À 3.89 Â 10 À3 ppm/K, is assumed to be involved in an intramolecular Hbond.
3. Conclusions. -The presented results show that methyl N-(2,2-dimethyl-2H-azirin-3-yl)-l-prolinate (1b) is a suitable building block for the incorporation of the (4) a ) Primed atoms refer to the molecule in the symmetry-related position x, y, 1 þ z. We thank the Analytical Sections of our institute for spectra and analyses, and the Swiss National Science Foundation and F. Hoffmann-La Roche AG, Basel, for financial support.
Experimental Part

1.
General. Solvents were purified by standard procedures. TLC: Merck TLC aluminum sheets, silica gel 60 F 254 . Column chromatography (CC): Uetikon-Chemie, silica gel C-560 (0.04 -0.063 mm, 230 -400 mesh). M.p.: Büchi Melting Point B-450 apparatus; uncorrected. IR Spectra: Perkin-Elmer, Spectrum one FT-IR spectrophotometer; in KBr unless otherwise stated; ñ in cm
À1
. NMR Spectra: Bruker AC-300 ( 1 H, 13 C, DEPT) at 300 and 75 MHz, resp., or Bruker DRX-600 ( 1 H, 13 C, HSQC, HMBC, COSY) at 600 and 150 MHz, resp., in CDCl 3 at 300 K unless otherwise stated; d in ppm, coupling constants J in Hz; 13 Csignal multiplicities from DEPT spectra. MS: Finnigan SSQ-700 (CI with NH 3 ), or Finningan TSQ-700 instrument (ESI); m/z (rel. %).
2. General Procedures. General Procedure 1 (GP 1). To a soln. of a peptide acid, 4-bromobenzoic acid (p-BrBz-OH) or 4-methoxybenzoic acid (p-MeOBz-OH) in dry THF or dry CH 2 Cl 2 , 2H-azirin-3-amine 1b (1.1 mol-equiv.) was added, and the mixture was stirred at r.t. After completion of the reaction (TLC), the soln. was concentrated in vacuo, and the residue was purified by CC (SiO 2 ). The solvent was evaporated, and the solid material was used without further purification.
General Procedure 2 (GP 2). To a soln. of the corresponding peptide methyl ester in THF/MeOH/ H 2 O 3 : 1 : 1, LiOH · H 2 O (4 mol-equiv.) was added. The mixture was stirred at r.t. After completion of the reaction (TLC), 1m HCl was added until pH 1 was reached, and the org. solvent was evaporated. The residue was extracted with CH 2 Cl 2 or AcOEt, the org. phases were dried (MgSO 4 ), the solvent was evaporated, and the residue was dried under h.v.
General Procedure 3 (GP 3). To a soln. of the peptide acid in dry CH 2 Cl 2 were added 1-hydroxy-1H-benzotriazole (HOBt, 1 mol-equiv.), 2-[(1H-benzotriazol-1-yl)oxy]-1,1,3,3-tetramethyluronium tetra- 3296m, 3054m, 2982m, 2952m, 2869w, 1750s, 1663s, 1616s, 1590w, 1538s,  1482m, 1422s, 1383w, 1362m, 1313m, 1286w, 1205s, 1168s, 1153w, 1096w, 1069m, 1012m, 989w, 906m,  847m, 792w, 764m, 749w, 709w, 3300m, 2984m, 2927m, 2874m, 1746s, 1646s, 1589w, 1537s, 1482w, 1468w 1403m,  1378w, 1326w, 1302m, 1243w, 1201w, 1168s, 1111w, 1094m, 1071m, 1049w, 956w, 944w, 907w, 880w, 848s , 761s, 708w, 631w, 625m, 612w. 2 -OH; 10). According to GP 2, 9 (503 mg, 0.869 mmol) in 20 ml of THF/MeOH/H 2 O, LiOH · H 2 O (145.8 mg, 3.476 mmol); stirring for 22 h: 455 mg (93%) of 10. The isolated peptide acid was pure enough to be used in the next step without further purification. 1 IR: 3272m, 2981m, 2945m, 2880w, 1749s, 1640s, 1588w,  1536s, 1480w, 1470w, 1406s, 1363w, 1198m, 1168s, 1110w, 1096w, 1071w, 1047w, 1009m, 853m, 810w, 760m , 709w, 664w, 611m. 
. Suitable crystals of 11 for the X-ray crystal-structure determination were grown from CH 2 Cl 2 / AcOEt by slow evaporation of the solvent at r.t. 3284m, 2983w, 2931m, 2872w, 1639s, 1589w,  1542s, 1483w, 1468w 1403m, 1378w, 1363w, 1316w, 1200w, 1174w, 1170m, 1010w, 922w, 851m, 761m, 728m . 
. Suitable crystals of 14 for the X-ray crystal-structure determination were grown from CH 2 Cl 2 by slow evaporation of the solvent at r.t. IR: 3285m, 2984m, 2938m,  2876w, 1745m, 1643s, 1590w, 1536m, 1469w, 1407s, 1380w, 1363w, 1304w, 1245w, 1202m, 1171m, 1094w,  1071w, 1011m, 926w, 849w, 761m, 173 (1) 160 (1) 160 (1) 173 (1 
parameters are compiled in Table 12 . The structures were solved by direct methods using either SIR92 [25] or SHELXS97 [26] . The crystal lattice of 11 contains highly disordered or diffuse solvent molecules. An analysis of the residual electron-density peaks suggests that partially occupied sites for CH 2 Cl 2 molecules are present, but it was not possible to adequately model their contribution to the overall structure in any logical manner. Therefore, the SQUEEZE routine [27] of the program PLATON [28] was employed. The procedure gave satisfactory R factors for the refinement and suitable geometric parameters for the peptide molecule, and there were no significant peaks of residual electron density to be found in the voids of the structure. The solvent molecules occupy a total volume of 866 3 per unit cell, divided into two symmetry-related regions. The electron count in the solvent region was calculated to be 42 e per unit cell. This corresponds with the presence of a total of one CH 2 Cl 2 molecule per unit cell, but spread across two symmetry-related sites. For the purposes of the calculation of the formula weight, density, F(000), and the linear absorption coefficient, it was assumed that the ratio of peptide 11 to CH 2 Cl 2 in the structure is 4 : 1.
The asymmetric unit of 14 contains one peptide and two CH 2 Cl 2 molecules, one of which is highly disordered. Three partially occupied sets of positions were defined for the Cl-atoms of the disordered solvent molecule, and the total occupancies of the sets of atoms were restrained to sum to 1.0. Similarity restraints were applied to the CÀCl bond lengths, while neighboring atoms within and between each orientation of the disordered CH 2 Cl 2 molecules were restrained to have similar and pseudo-isotropic atomic displacement parameters.
In the case of 18, the asymmetric unit contains one peptide and one highly disordered CH 2 Cl 2 molecule plus a site for a H 2 O molecule which is only one quarter occupied. Two equally occupied positions were defined for each of the Cl-atoms of the CH 2 Cl 2 molecule, but the large values for their atomic displacement ellipsoids suggest that this molecule is even more highly disordered within its cavity. The H 2 O molecule site is actually very close to that of the CH 2 Cl 2 molecule, and it is possible that either the H 2 O molecule is disordered with the CH 2 Cl 2 molecule, or there is no H 2 O at all, and that the electron density that has been assigned to the H 2 O O-atom actually represents another low occupancy disordered position for an atom of the CH 2 Cl 2 molecule. However, the refined model appears to provide the best match with the electron density in the solvent region. The central five-membered ring of the peptide molecule has a disordered envelope conformation in which the envelope flap atom, C (26) , is flipped alternately to both sides of the ring. The major conformation of this ring occurs in 56(2)% of the molecules. The other five-membered ring also shows slight evidence for similar disorder involving C(31), but a disordered model could not be refined satisfactorily.
For all structures, the non-H atoms were refined anisotropically. The amide H-atoms of 14 and 18 were located in a difference electron density map, and their positions were allowed to refine together with individual isotropic displacement parameters. The H-atoms of the CH 2 Cl 2 and H 2 O solvent molecules of 18 were not included in the model. All of the remaining H-atoms in each structure were placed in geometrically calculated positions and refined using a riding model where each H-atom was assigned a fixed isotropic displacement parameter with a value equal to 1.2 U eq of its parent C-atom (1.5U eq for the Me groups). The refinement of each structure was carried out on F 2 using full-matrix leastsquares procedures [26] , which minimized the function Sw(F 2 . Corrections for secondary extinction were applied for 11 and 14. Between two and four reflections whose intensities were considered as outliers were omitted from the final refinement of each structure. Refinement of the absolute structure parameter [29] confidently confirmed that the refined model represents the true enantiomorph for 11, 14, and 15 (Table 12) , which is consistent with the peptide configurations expected from the synthesis. The absolute structure for 18 could not be determined owing to the weak anomalous scattering of the material. The enantiomer used in the refinement was based on the known (S)-configuration at C(5) and C (11) .
Neutral atom scattering factors for non-H-atoms were taken from [30a] , and the scattering factors for H-atoms were taken from [31] . Anomalous dispersion effects were included in F c [32] ; the values for f ' and f '' were those of [30b] . The values of the mass attenuation coefficients are those of [30c]. All calculations were performed using the SHELXL97 [26] program.
